NCT01722110View on ClinicalTrials.gov

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Fed
Interventions
DRUG

Indomethacin Extended-Release Capsules USP 75 mg

75 mg tablet once a day

DRUG

Indomethacin Extended Release Capsules USP 75 mg

75 mg tablet once a day

Trial Locations (1)

400 709

Accutest Research Lab (I) Pvt. Ltd., Navi Mumbai

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY